New York Life Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.5M Sell
32,336
-472
-1% -$175K 0.09% 182
2026
Q1
$9.6M Buy
32,808
+519
+2% +$171K 0.08% 210
2025
Q4
$11.3M Sell
32,289
-552
-2% -$187K 0.1% 175
2025
Q3
$10.6M Sell
32,841
-1,649
-5% -$513K 0.09% 189
2025
Q2
$13.4M Sell
34,490
-602
-2% -$242K 0.13% 151
2025
Q1
$15.3M Sell
35,092
-283
-0.8% -$114K 0.16% 127
2024
Q4
$13M Buy
35,375
+452
+1% +$189K 0.13% 146
2024
Q3
$18.2M Sell
34,923
-1,098
-3% -$587K 0.18% 110
2024
Q2
$19.5M Sell
36,021
-46
-0.1% -$24.3K 0.2% 103
2024
Q1
$18.7M Sell
36,067
-1,201
-3% -$597K 0.19% 100
2023
Q4
$17.6M Sell
37,268
-4,999
-12% -$2.31M 0.18% 106
2023
Q3
$18.4M Sell
42,267
-1,032
-2% -$468K 0.2% 96
2023
Q2
$19.2M Sell
43,299
-445
-1% -$205K 0.2% 100
2023
Q1
$20.1M Sell
43,744
-263
-0.6% -$125K 0.22% 98
2022
Q4
$22.6M Sell
44,007
-451
-1% -$229K 0.26% 82
2022
Q3
$20.2M Sell
44,458
-550
-1% -$263K 0.24% 83
2022
Q2
$21.7M Buy
+45,008
New +$22.3M 0.25% 79
2014
Q4
Sell
-1,000
Closed -$120K 268
2014
Q3
$120K Hold
1,000
0.02% 174
2014
Q2
$108K Hold
1,000
0.02% 180
2014
Q1
$100K Buy
+1,000
New +$90.4K 0.02% 144

Other funds holding ELV

New York Life Investment Management's ELV Position: Q2 2026 in Review

New York Life Investment Management reduced its Elevance Health (ELV) stake by 1.4% in Q2 2026, selling an estimated $175K and leaving 32,336 shares worth $12.5M. The position accounts for 0.09% of the portfolio, ranked #182.

New York Life Investment Management first reported a position in ELV in Q1 2014 and has held it in 20 quarters since. The position peaked at $22.6M in Q4 2022. 1,176 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • New York Life Investment Management held 32,336 shares of Elevance Health worth $12.5M as of Q2 2026.
  • New York Life Investment Management sold 472 Elevance Health shares in Q2 2026, an estimated $175K.
  • Elevance Health made up 0.09% of New York Life Investment Management's portfolio in Q2 2026, its #182 holding.
  • New York Life Investment Management first reported a position in Elevance Health in Q1 2014 and has held it in 20 quarters since.
  • New York Life Investment Management's Elevance Health position peaked at $22.6M in Q4 2022.
  • 1,176 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.